Find News

Filter articles

Applied Filters

Showing 81 to 90 of 313 results

Finnegan partner joins Quinn Emanuel in Tokyo


York Faulkner, an IP partner from Finnegan, Henderson, Farabow, Garrett & Dunner, has joined Quinn Emanuel Urquhart & Sullivan in Tokyo.

Epstein Becker Green adds FDA specialist to team


Neil Di Spirito has left Ballard Spahr to join Epstein Becker Green as a member of the firm’s healthcare and life sciences practice.

Medtech company backs down from Pfizer TM oppositions


Medical technology company Biocompatibles UK last week withdrew its oppositions to two trademarks applied for by Pfizer, four months after settlement negotiations.

UK shares Brexit implementation plans for life sciences

EU, UK06-08-2018

The UK government today published four documents about how Brexit will impact the operations and regulatory status of life sciences companies.

DNA from tomatoes could prevent counterfeit breast implants, say researchers


German scientists claim to have developed a way of identifying counterfeit breast implants by using DNA sequences from tomatoes.

Morgan Lewis strengthens team with seven McDermott partners


Morgan Lewis & Bockius has boosted its IP litigation team with the addition of seven partners from McDermott Will & Emery who have experience in the life sciences and technology industries.

King & Spalding adds another patent lawyer from Paul Hastings


Vanessa Yen has joined King & Spalding's trial and global disputes practice group as a partner after leaving Paul Hastings.

Sun Pharma unit bolsters patent suit with trade secrets claims

India, US12-07-2018

Dusa Pharmaceuticals, a subsidiary of India-based generic drug maker Sun Pharma, has accused dermatology-focused company Biofrontera of misappropriating trade secrets.

US tariffs on med tech prevent patient access: trade association

China, US09-07-2018

A medical technology trade association has warned that the US tariffs recently implemented in response to Chinese IP theft may hinder patient access to life-saving technologies.

Novartis launches Nerve platform to harness ‘data revolution’


Novartis has created a platform called Nerve Live that will tap into its “huge data pool” in order to aid drug development.

Showing 81 to 90 of 313 results